BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Deargen

Deargen logo

Founded
2016
Patents
3
Publications
16

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology.
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization.
DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.

Become a Member to view additional information about this company